We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mettler-Toledo (MTD) to Post Q2 Earnings: What's in Store?
Read MoreHide Full Article
Mettler-Toledo International, Inc. (MTD - Free Report) is scheduled to report second-quarter 2020 results on Jul 30. In the last reported quarter, the company delivered an earnings surprise of 0.5%.
It topped the Zacks Consensus Estimate in all the trailing four quarters, delivering average surprise of 1.03%.
Second-Quarter Expectations
Mettler-Toledo expects anticipates sales to decline between 8% and 12% on a year-over-year basis in local currency. The Zacks Consensus Estimate for sales is pegged at $647.43 million.
Adjusted earnings are anticipated in the range of $4.05-$4.45 per share. The Zacks Consensus Estimate for earnings is pegged at $4.27 per share.
MettlerToledo International, Inc. Price and EPS Surprise
Mettler-Toledo reported second-quarter 2020 adjusted earnings of $4 per share, beating the Zacks Consensus Estimate by 0.5%.
Revenues of $649.2 million missed the Zacks Consensus Estimate of $650 million.
Let’s see how things have shaped up for this announcement.
Key Factors to Consider
The company’s strong product portfolio, which includes robust analytical instruments, balances and auto-chem, is expected to have driven sales in the to-be-reported quarter.
Further, strength across Laboratory and Industrial segments is anticipated to have contributed to its second-quarter performance.
The company’s strong momentum across pharmaceutical and life sciences markets are expected to have driven the performance in the quarter under review. Further, investments in field force, Spinnaker sales and marketing programs may get reflected in the results for the quarter to be reported. Further, its robust automated chemistry solutions are expected to have aided Mettler-Toledo’s momentum across the drug process development field in the quarter under review.
The Zacks Consensus Estimate for the Laboratory segment sales is pegged at $327 million, indicating a decline of 13.9% from the year-ago reported figure.
Mettler-Toledo’s solid momentum across core industrial business is likely to have driven the Industrial Instruments’ segment sales in the second quarter amid sluggishness in the product inspection business.
The Zacks Consensus Estimate for the Industrial segment sales is pegged at $278 million, suggesting a decline of 8.3% from the prior-year quarter.
Nonetheless, the company’s cost-containment measures and declining discretionary spending are expected to have aided the segment’s performance in the to-be-reported quarter.
However, lab demand is expected to have been weak in the second quarter as labs were not fully operational due to work-from-home restrictions. Also, softness in the Mettler-Toledo’s retail segment — which comprises food retail business — might have acted as a headwind in the second quarter. The Zacks Consensus Estimate for Retail segment sales is pegged at $35 million, suggesting a decline of 28.1% from the prior-year quarter.
What Our Model Says
Our proven model predicts an earnings beat for Mettler-Toledo this time around. The combination of a positive MTD Quick QuoteMTD - Free Report) %20is%20scheduled%20to%20report%20second-quarter%202020%20results%20on%20Jul%2030.%20In%20the%20last%20reported%20quarter,%20the%20company%20delivered%20an%20earnings%20surprise%20of%200.5%.%20%20It%20topped%20the%20Zacks%20Consensus%20Estimate%20in%20all%20the%20trailing%20four%20quarters,%20delivering%20average%20surprise%20of%201.03%.%20%20Second-Quarter%20Expectations%20%20Mettler-Toledo%20expects%20anticipates%20sales%20to%20decline%20between%208%%20and%2012%%20on%20a%20year-over-year%20basis%20in%20local%20currency.%20The%20Zacks%20Consensus%20Estimate%20for%20sales%20is%20pegged%20at%20%24647.43%20million.%20%20Adjusted%20earnings%20are%20anticipated%20in%20the%20range%20of%20%244.05-%244.45%20per%20share.%20The%20Zacks%20Consensus%20Estimate%20for%20earnings%20is%20pegged%20at%20%244.27%20per%20share.%20%20Performance%20in%20the%20Last%20Reported%20Quarter%20%20Mettler-Toledo%20reported%20second-quarter%202020%20adjusted%20earnings%20of%20%244%20per%20share,%20beating%20the%20Zacks%20Consensus%20Estimate%20by%200.5%.%20%20%20Revenues%20of%20%24649.2%20million%20missed%20the%20Zacks%20Consensus%20Estimate%20of%20%24650%20million.%20%20Let???s%20see%20how%20things%20have%20shaped%20up%20for%20this%20announcement.%20%20Key%20Factors%20to%20Consider%20%20The%20company???s%20strong%20product%20portfolio,%20which%20includes%20robust%20analytical%20instruments,%20balances%20and%20auto-chem,%20is%20expected%20to%20have%20driven%20sales%20in%20the%20to-be-reported%20quarter.%20%20Further,%20strength%20across%20Laboratory%20and%20Industrial%20segments%20is%20anticipated%20to%20have%20contributed%20to%20its%20second-quarter%20performance.%20%20The%20company???s%20strong%20momentum%20across%20pharmaceutical%20and%20life%20sciences%20markets%20are%20expected%20to%20have%20driven%20the%20performance%20in%20the%20quarter%20under%20review.%20Further,%20investments%20in%20field%20force,%20Spinnaker%20sales%20and%20marketing%20programs%20may%20get%20reflected%20in%20the%20results%20for%20the%20quarter%20to%20be%20reported.%20Further,%20its%20robust%20automated%20chemistry%20solutions%20are%20expected%20to%20have%20aided%20Mettler-Toledo???s%20momentum%20across%20drug%20process%20development%20field%20in%20the%20quarter%20under%20review.%20%20%20The%20Zacks%20Consensus%20Estimate%20for%20the%20Laboratory%20segment%20sales%20is%20pegged%20at%20%24327%20million,%20indicating%20a%20decline%20of%2013.9%%20from%20the%20year-ago%20reported%20figure.%20%20Mettler-Toledo???s%20solid%20momentum%20across%20core%20industrial%20business%20is%20likely%20to%20have%20driven%20the%20Industrial%20Instruments???%20segment%20sales%20in%20the%20second%20quarter%20amid%20sluggishness%20in%20the%20product%20inspection%20business.%20%20The%20Zacks%20Consensus%20Estimate%20for%20the%20Industrial%20segment%20sales%20is%20pegged%20at%20%24278%20million,%20suggesting%20a%20decline%20of%208.3%%20from%20the%20prior-year%20quarter.%20%20Nonetheless,%20the%20company???s%20cost-containment%20measures%20and%20declining%20discretionary%20spending%20are%20expected%20to%20have%20aided%20the%20segment???s%20performance%20in%20the%20to-be-reported%20quarter.%20%20However,%20lab%20demand%20is%20expected%20to%20have%20been%20weak%20in%20the%20second%20quarter%20as%20labs%20were%20not%20fully%20operational%20due%20to%20work-from-home%20restrictions.%20Also,%20softness%20in%20the%20Mettler-Toledo???s%20retail%20segment%20???%20which%20comprises%20food%20retail%20business%20???%20might%20have%20acted%20as%20a%20headwind%20in%20the%20second%20quarter.%20The%20Zacks%20Consensus%20Estimate%20for%20Retail%20segment%20sales%20is%20pegged%20at%20%2435%20million,%20suggesting%20a%20decline%20of%2028.1%%20from%20the%20prior-year%20quarter.%20%20What%20Our%20Model%20Says%20%20Our%20proven%20model%20predicts%20an%20earnings%20beat%20for%20Mettler-Toledo%20this%20time%20around.%20The%20combination%20of%20a%20positive%20Earnings%20ESP%20and%20a%20Zacks%20Rank%20#1%20(Strong%20Buy),%202%20(Buy)%20or%203%20(Hold)%20increases%20the%20odds%20of%20an%20earnings%20beat.%20You%20can%20uncover%20the%20best%20stocks%20to%20buy%20or%20sell%20before%20they???re%20reported%20with%20our%20Earnings%20ESP%20Filter.%20%20Mettler-Toledo%20has%20an%20Earnings%20ESP%20of%20+3.51%%20and%20a%20Zacks%20Rank%20#2.%20%20Other%20Stocks%20to%20Consider%20%20Here%20are%20some%20other%20companies,%20which%20also%20have%20the%20right%20combination%20of%20elements%20to%20post%20an%20earnings%20beat%20in%20the%20quarter%20to%20be%20reported:%20%20NXP%20Semiconductors%20N.V.%20(NXPI - Free Report) %20has%20an%20Earnings%20ESP%20of%20+11.90%%20and%20holds%20a%20Zacks%20Rank%20of%202.%20%20Etsy,%20Inc.%20(ETSY - Free Report) %20has%20an%20Earnings%20ESP%20of%20+1.15%%20and%20a%20Zacks%20Rank%20#2.%20You%20can%20see%20the%20complete%20list%20of%20today???s%20Zacks%20#1%20Rank%20stocks%20here.%20%20PerkinElmer,%20Inc.%20%20has%20an%20Earnings%20ESP%20of%20+22.13%%20and%20holds%20a%20Zacks%20Rank%20of%201.%20%20Zacks%20Top%2010%20Stocks%20for%202020%20%20In%20addition%20to%20the%20stocks%20discussed%20above,%20would%20you%20like%20to%20know%20about%20our%2010%20finest%20buy-and-hold%20tickers%20for%20the%20entirety%20of%202020?%20%20%20Last%20year's%202019%20Zacks%20Top%2010%20Stocks%20portfolio%20returned%20gains%20as%20high%20as%20+102.7%.%20Now%20a%20brand-new%20portfolio%20has%20been%20handpicked%20from%20over%204,000%20companies%20covered%20by%20the%20Zacks%20Rank.%20Don???t%20miss%20your%20chance%20to%20get%20in%20on%20these%20long-term%20buys.%20%20%20Access%20Zacks%20Top%2010%20Stocks%20for%202020%20today%20>>">Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Mettler-Toledo has an Earnings ESP of +3.51% and a Zacks Rank #2.
Other Stocks to Consider
Here are some other companies, which also have the right combination of elements to post an earnings beat in the quarter to be reported:
NXP Semiconductors N.V. (NXPI - Free Report) has an Earnings ESP of +11.90% and holds a Zacks Rank of 2.
PerkinElmer, Inc. has an Earnings ESP of +22.13% and holds a Zacks Rank of 1.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
Mettler-Toledo (MTD) to Post Q2 Earnings: What's in Store?
Mettler-Toledo International, Inc. (MTD - Free Report) is scheduled to report second-quarter 2020 results on Jul 30. In the last reported quarter, the company delivered an earnings surprise of 0.5%.
It topped the Zacks Consensus Estimate in all the trailing four quarters, delivering average surprise of 1.03%.
Second-Quarter Expectations
Mettler-Toledo expects anticipates sales to decline between 8% and 12% on a year-over-year basis in local currency. The Zacks Consensus Estimate for sales is pegged at $647.43 million.
Adjusted earnings are anticipated in the range of $4.05-$4.45 per share. The Zacks Consensus Estimate for earnings is pegged at $4.27 per share.
MettlerToledo International, Inc. Price and EPS Surprise
MettlerToledo International, Inc. price-eps-surprise | MettlerToledo International, Inc. Quote
Performance in the Last Reported Quarter
Mettler-Toledo reported second-quarter 2020 adjusted earnings of $4 per share, beating the Zacks Consensus Estimate by 0.5%.
Revenues of $649.2 million missed the Zacks Consensus Estimate of $650 million.
Let’s see how things have shaped up for this announcement.
Key Factors to Consider
The company’s strong product portfolio, which includes robust analytical instruments, balances and auto-chem, is expected to have driven sales in the to-be-reported quarter.
Further, strength across Laboratory and Industrial segments is anticipated to have contributed to its second-quarter performance.
The company’s strong momentum across pharmaceutical and life sciences markets are expected to have driven the performance in the quarter under review. Further, investments in field force, Spinnaker sales and marketing programs may get reflected in the results for the quarter to be reported. Further, its robust automated chemistry solutions are expected to have aided Mettler-Toledo’s momentum across the drug process development field in the quarter under review.
The Zacks Consensus Estimate for the Laboratory segment sales is pegged at $327 million, indicating a decline of 13.9% from the year-ago reported figure.
Mettler-Toledo’s solid momentum across core industrial business is likely to have driven the Industrial Instruments’ segment sales in the second quarter amid sluggishness in the product inspection business.
The Zacks Consensus Estimate for the Industrial segment sales is pegged at $278 million, suggesting a decline of 8.3% from the prior-year quarter.
Nonetheless, the company’s cost-containment measures and declining discretionary spending are expected to have aided the segment’s performance in the to-be-reported quarter.
However, lab demand is expected to have been weak in the second quarter as labs were not fully operational due to work-from-home restrictions. Also, softness in the Mettler-Toledo’s retail segment — which comprises food retail business — might have acted as a headwind in the second quarter. The Zacks Consensus Estimate for Retail segment sales is pegged at $35 million, suggesting a decline of 28.1% from the prior-year quarter.
What Our Model Says
Our proven model predicts an earnings beat for Mettler-Toledo this time around. The combination of a positive MTD Quick QuoteMTD - Free Report) %20is%20scheduled%20to%20report%20second-quarter%202020%20results%20on%20Jul%2030.%20In%20the%20last%20reported%20quarter,%20the%20company%20delivered%20an%20earnings%20surprise%20of%200.5%.%20%20It%20topped%20the%20Zacks%20Consensus%20Estimate%20in%20all%20the%20trailing%20four%20quarters,%20delivering%20average%20surprise%20of%201.03%.%20%20Second-Quarter%20Expectations%20%20Mettler-Toledo%20expects%20anticipates%20sales%20to%20decline%20between%208%%20and%2012%%20on%20a%20year-over-year%20basis%20in%20local%20currency.%20The%20Zacks%20Consensus%20Estimate%20for%20sales%20is%20pegged%20at%20%24647.43%20million.%20%20Adjusted%20earnings%20are%20anticipated%20in%20the%20range%20of%20%244.05-%244.45%20per%20share.%20The%20Zacks%20Consensus%20Estimate%20for%20earnings%20is%20pegged%20at%20%244.27%20per%20share.%20%20Performance%20in%20the%20Last%20Reported%20Quarter%20%20Mettler-Toledo%20reported%20second-quarter%202020%20adjusted%20earnings%20of%20%244%20per%20share,%20beating%20the%20Zacks%20Consensus%20Estimate%20by%200.5%.%20%20%20Revenues%20of%20%24649.2%20million%20missed%20the%20Zacks%20Consensus%20Estimate%20of%20%24650%20million.%20%20Let???s%20see%20how%20things%20have%20shaped%20up%20for%20this%20announcement.%20%20Key%20Factors%20to%20Consider%20%20The%20company???s%20strong%20product%20portfolio,%20which%20includes%20robust%20analytical%20instruments,%20balances%20and%20auto-chem,%20is%20expected%20to%20have%20driven%20sales%20in%20the%20to-be-reported%20quarter.%20%20Further,%20strength%20across%20Laboratory%20and%20Industrial%20segments%20is%20anticipated%20to%20have%20contributed%20to%20its%20second-quarter%20performance.%20%20The%20company???s%20strong%20momentum%20across%20pharmaceutical%20and%20life%20sciences%20markets%20are%20expected%20to%20have%20driven%20the%20performance%20in%20the%20quarter%20under%20review.%20Further,%20investments%20in%20field%20force,%20Spinnaker%20sales%20and%20marketing%20programs%20may%20get%20reflected%20in%20the%20results%20for%20the%20quarter%20to%20be%20reported.%20Further,%20its%20robust%20automated%20chemistry%20solutions%20are%20expected%20to%20have%20aided%20Mettler-Toledo???s%20momentum%20across%20drug%20process%20development%20field%20in%20the%20quarter%20under%20review.%20%20%20The%20Zacks%20Consensus%20Estimate%20for%20the%20Laboratory%20segment%20sales%20is%20pegged%20at%20%24327%20million,%20indicating%20a%20decline%20of%2013.9%%20from%20the%20year-ago%20reported%20figure.%20%20Mettler-Toledo???s%20solid%20momentum%20across%20core%20industrial%20business%20is%20likely%20to%20have%20driven%20the%20Industrial%20Instruments???%20segment%20sales%20in%20the%20second%20quarter%20amid%20sluggishness%20in%20the%20product%20inspection%20business.%20%20The%20Zacks%20Consensus%20Estimate%20for%20the%20Industrial%20segment%20sales%20is%20pegged%20at%20%24278%20million,%20suggesting%20a%20decline%20of%208.3%%20from%20the%20prior-year%20quarter.%20%20Nonetheless,%20the%20company???s%20cost-containment%20measures%20and%20declining%20discretionary%20spending%20are%20expected%20to%20have%20aided%20the%20segment???s%20performance%20in%20the%20to-be-reported%20quarter.%20%20However,%20lab%20demand%20is%20expected%20to%20have%20been%20weak%20in%20the%20second%20quarter%20as%20labs%20were%20not%20fully%20operational%20due%20to%20work-from-home%20restrictions.%20Also,%20softness%20in%20the%20Mettler-Toledo???s%20retail%20segment%20???%20which%20comprises%20food%20retail%20business%20???%20might%20have%20acted%20as%20a%20headwind%20in%20the%20second%20quarter.%20The%20Zacks%20Consensus%20Estimate%20for%20Retail%20segment%20sales%20is%20pegged%20at%20%2435%20million,%20suggesting%20a%20decline%20of%2028.1%%20from%20the%20prior-year%20quarter.%20%20What%20Our%20Model%20Says%20%20Our%20proven%20model%20predicts%20an%20earnings%20beat%20for%20Mettler-Toledo%20this%20time%20around.%20The%20combination%20of%20a%20positive%20Earnings%20ESP%20and%20a%20Zacks%20Rank%20#1%20(Strong%20Buy),%202%20(Buy)%20or%203%20(Hold)%20increases%20the%20odds%20of%20an%20earnings%20beat.%20You%20can%20uncover%20the%20best%20stocks%20to%20buy%20or%20sell%20before%20they???re%20reported%20with%20our%20Earnings%20ESP%20Filter.%20%20Mettler-Toledo%20has%20an%20Earnings%20ESP%20of%20+3.51%%20and%20a%20Zacks%20Rank%20#2.%20%20Other%20Stocks%20to%20Consider%20%20Here%20are%20some%20other%20companies,%20which%20also%20have%20the%20right%20combination%20of%20elements%20to%20post%20an%20earnings%20beat%20in%20the%20quarter%20to%20be%20reported:%20%20NXP%20Semiconductors%20N.V.%20(NXPI - Free Report) %20has%20an%20Earnings%20ESP%20of%20+11.90%%20and%20holds%20a%20Zacks%20Rank%20of%202.%20%20Etsy,%20Inc.%20(ETSY - Free Report) %20has%20an%20Earnings%20ESP%20of%20+1.15%%20and%20a%20Zacks%20Rank%20#2.%20You%20can%20see%20the%20complete%20list%20of%20today???s%20Zacks%20#1%20Rank%20stocks%20here.%20%20PerkinElmer,%20Inc.%20%20has%20an%20Earnings%20ESP%20of%20+22.13%%20and%20holds%20a%20Zacks%20Rank%20of%201.%20%20Zacks%20Top%2010%20Stocks%20for%202020%20%20In%20addition%20to%20the%20stocks%20discussed%20above,%20would%20you%20like%20to%20know%20about%20our%2010%20finest%20buy-and-hold%20tickers%20for%20the%20entirety%20of%202020?%20%20%20Last%20year's%202019%20Zacks%20Top%2010%20Stocks%20portfolio%20returned%20gains%20as%20high%20as%20+102.7%.%20Now%20a%20brand-new%20portfolio%20has%20been%20handpicked%20from%20over%204,000%20companies%20covered%20by%20the%20Zacks%20Rank.%20Don???t%20miss%20your%20chance%20to%20get%20in%20on%20these%20long-term%20buys.%20%20%20Access%20Zacks%20Top%2010%20Stocks%20for%202020%20today%20>>">Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Mettler-Toledo has an Earnings ESP of +3.51% and a Zacks Rank #2.
Other Stocks to Consider
Here are some other companies, which also have the right combination of elements to post an earnings beat in the quarter to be reported:
NXP Semiconductors N.V. (NXPI - Free Report) has an Earnings ESP of +11.90% and holds a Zacks Rank of 2.
Etsy, Inc. (ETSY - Free Report) has an Earnings ESP of +1.15% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
PerkinElmer, Inc. has an Earnings ESP of +22.13% and holds a Zacks Rank of 1.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>